Provided by Planning Commission of India
Investment Pattern in India
Provided by Reserve Bank of India
Provided by CSO of India
Provided by PIB.nic.in
5 January 2018
India GDP at current prices in the year 2017-18 is likely to attain a level of `166.28 lakh crore, as against `151.84 lakh crore in 2016-17 showing a growth rate of 9.5 per cent.
More details available: http://pib.nic.in/newsite/PrintRelease.aspx?relid=175399
GDP growth will become more robust in 2018-19: NITI Aayog
The Vice Chairman of NITI Aayog, Dr. Rajiv Kumar has said that the GDP growth will become more robust in 2018-19. Reacting on the growth estimates released today, he said that the Second half GDP growth in 2017-18 has risen to 7% bringing the annual growth rate to 6.5%. The Vice Chairman, NITI Aayog pointed out that economic activity has been picking up over the last three quarters and can be expected to strengthen in the coming period with the manufacturing PMI now reading at a five year high of 54%, and FMCG demand picking up briskly. Hence the GDP growth will become more robust in 2018-19.
5 -January-2018 03:32IST
Growth of Indian Economy
As per the World Economic Situation and Prospects 2018 report of the United Nations, the Indian economy is projected to grow at 7.2 per cent in 2018-19 and 7.4 per cent in 2019-20. The report indicates that the outlook for India remains largely positive, underpinned by robust private consumption and public investment as well as ongoing structural reforms.
Estimates of Gross Domestic Product for the First Quarter (April-June) of 2017-18
Provisional Estimates of Annual National Income, 2016-17 And Quarterly Estimates of Gross Domestic Product, 2016-17
31 August 2015
GDP at current prices in Q1 of 2015-16 is estimated at `32.43 lakh crore, as against `29.80 lakh crore in Q1 of 2014-15, showing a growth rate of 8.8 percent.
Private Final Consumption Expenditure (PFCE) at current prices is estimated at `19.89 lakh crore in Q1 of 2015-16 as against `18.10 lakh crore in Q1 of 2014-15.
Government Final Consumption Expenditure (GFCE) at current prices is estimated at `3.86 lakh crore in Q1 of 2015-16 as against `3.71 lakh crore in Q1 of 2014-15.
Gross Fixed Capital Formation (GFCF) at current prices is estimated at ` 9.02 lakh crore in Q1 of 2015-16 as against `8.69 lakh crore in Q1 of 2014-15.
Corporate Sector News
11 Sep 2015
Indigo posts record net profit of Rs. 1,304 cr for FY 2015.
Cross Border Acquisitions by Indian Pharma Companies
Sun Pharma bought opioid business of GSK Pharma for undisclosed amount.
Dr. Reddy's bought Belgian Company UCB's brands for $128 million
Strides bought Aspen Pharma's Australian assets for $287 million
Lupin bought Gavis in USA for $880 million
Cipla bought Invagen and Exelan for $550 million
Updated 6 January 2018, 11 September 2015